Caster Semenya has had an appeal dismissed by CAS to halt the introduction of regulations which will limit testosterone in female athletes with differences in sexual development.
South African athlete Castor Semenya has had her appeal to halt the introduction of regulations to limit testosterone in female athletesAthletes with differences in sexual development will now have to take medication in order to compete in events ranging from 400-metres to a mile
Wednesday's CAS ruling upholds the International Association of Athletics Federations recommendations, meaning that regulations are to be introduced aimed at ensuring fair competition between athletes who compete in distance events ranging from 400-meters to a mile.In future, female athletes will be required to have reduced their blood testosterone level to below the stipulated concentration for a period of six months before they can compete.
Semenya took potential steps to reinvent her career last week when she won the 5,000-meters at the South African Athletics Championships in a modest time of 16:05.97, an event that would allow her to compete outside of the IAAF regulations.
Malaysia Latest News, Malaysia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Semenya loses appeal against IAAF testosterone rulesThe IAAF believes female runners with high testosterone levels have an unfair advantage in events from 400 meters to the mile.
Read more »
Caster Semenya loses appeal: track federation may regulate women with naturally high testosterone levelsSouth African runner Caster Semenya has lost her appeal against track officials who may now proceed to judge female athletes by their body chemistry.
Read more »
Caster Semenya loses appeal in controversial case over IAAF's testosterone rulesSemenya, a two-time Olympic champion in the 800 meters, will now be forced to medicate to suppress her testosterone levels if she wants to defend her world title.
Read more »
Caster Semenya loses landmark testosterone rule caseDouble Olympic champion Caster Semenya has lost her appeal against the introduction of new rules regulating the testosterone levels for athletes with a difference in sex development (DSD).
Read more »
Court says Olympian Caster Semenya, thought to have an intersex condition, cannot compete unless she uses hormone-suppressing drugsThe Court of Arbitration for Sport issued the ruling related to the South African middle-distance runner, who is thought to have an intersex condition that causes her body to produce increased testosterone. The International Association of Athletics Federations, the world governing body for track and field, had previously instituted rules that precluded Semenya from competing […]
Read more »
Court rules that barring women with high testosterone from some international track events is discriminatory but 'necessary, reasonable and proportionate'Caster Semenya has lost her appeal against rules designed to decrease naturally high testosterone levels in some female runners.
Read more »
Semenya loses appeal against IAAF testosterone rulesLAUSANNE, Switzerland (AP) — Caster Semenya lost her appeal Wednesday against rules designed to decrease naturally high testosterone levels in some female runners. The Court of Arbitration...
Read more »
Caster Semenya loses landmark testosterone rule caseDouble Olympic champion Caster Semenya has lost her appeal against the introduction of new rules regulating the testosterone levels for athletes with a difference in sex development (DSD).
Read more »
Caster Semenya loses appeal: track federation may regulate women with naturally high testosterone levelsSouth African runner Caster Semenya has lost her appeal against track officials who may now proceed to judge female athletes by their body chemistry.
Read more »
Caster Semenya loses appeal in controversial case over IAAF's testosterone rulesSemenya, a two-time Olympic champion in the 800 meters, will now be forced to medicate to suppress her testosterone levels if she wants to defend her world title.
Read more »